My selection for this issue is the article ‘Social Impact and Quality of Life of Patients with β-Thalassemia: A Systematic Review’ by Greco and Marino. Quality of life is becoming more and more important in the evaluation of clinical trials, and also by regulatory authorities, particularly in chronic diseases (which can be seen by the U.S. Food and Drug Administration’s [FDA] recent position on luspatercept). Therefore, understanding its meaning and limitations is very important.

Novel study findings have highlighted how the appearance of ovarian lesions on ultrasound can be an effective predictor of cancer risk…

Artificial imaging has been implemented into medical imaging to enhance the precision and reliability of diagnosis…

Exploring the pharmaceutical landscape in South Africa, GOLD considers several areas that are shaping the nation’s role in the future of global pharmaceuticals

Vitiligo is an acquired skin depigmenting disorder resulting from melanocytes loss in the epidermis, associated with an autoimmune aetiopathophysiology. However, there are limited data about the association between vitiligo and Epstein–Barr virus (EBV).

A new filmmaking project is sponsored by BioMarin Pharmaceutical to support people with haemophilia, exploring the healing and therapeutic power of arts and self expression.

In the light of their journey through urological texts, the authors propose that the prostate screening collaborating with PSA measurements should continue..

A study has indicated that fetal exposure to mother’s medication could affect the new-born’s brain development…